Home Infusion Therapy Market Size, Share, Latest Insights and Forecast 2026-2034

According to IMARC Group, the global home infusion therapy market size reached USD 47.7 Billion in 2025 and is projected to reach USD 72.8 Billion by 2034, expanding at a CAGR of 4.65% during 2026–2034. This sustained Home Infusion Therapy Market Growth is being driven by a growing elderly population, rising preference for home-based healthcare, continuous advancements in infusion pump technology, and the increasing prevalence of chronic conditions that require long-term, cost-effective treatment outside the hospital setting.

Home Infusion Therapy Industry Overview

Home infusion therapy encompasses the delivery of intravenous and subcutaneous medications, fluids, and nutritional formulations to patients in a non-hospital setting, typically supported by a combination of infusion pumps, intravenous sets, cannulas, and needleless connectors, along with trained home-care nursing support. By moving treatment away from centralized facilities, home infusion reduces exposure to hospital-acquired infections, lowers per-episode treatment costs, and significantly improves patient comfort and quality of life during extended courses of therapy.

Home infusion therapy is deployed across a broad continuum of clinical applications:

• Anti-infective therapy: Intravenous antibiotic administration for severe infections such as pneumonia and other conditions requiring extended antimicrobial courses
• Endocrinology: Diabetes management and other hormone-related infusion therapies delivered through wearable and ambulatory pump systems
• Hydration therapy: Fluid replacement for athletes and general patients requiring at-home rehydration support
• Chemotherapy: Oncology treatment delivered in a home setting to reduce hospital visit frequency for eligible patients
• Enteral and parenteral nutrition: Long-term nutritional support for patients unable to meet nutritional needs through oral intake
• Specialty pharmaceuticals: Complex biologic and specialty drug regimens requiring professional infusion support at home

Global Home Infusion Therapy Market Size & Key Statistics

Below are the key Home Infusion Therapy Market statistics drawn from IMARC Group’s comprehensive market analysis:

Base Year - 2025

Historical Period - 2020–2025

Forecast Period - 2026–2034

Home Infusion Therapy Market Size in 2025 - USD 47.7 Billion

Market Forecast in 2034 - USD 72.8 Billion

Market Growth Rate (2026–2034) - 4.65% CAGR

Largest Region - North America

Leading Product Segment - Infusion Pumps

Leading Application - Anti-Infective

Request for a Sample Report for Detailed Home Infusion Therapy Market Share Evaluation: https://www.imarcgroup.com/home-infusion-therapy-market/requestsample

Key Market Drivers & Home Infusion Therapy Market Trends in 2026

Several powerful forces are shaping Home Infusion Therapy Market Trends and fuelling sustained growth expectations across global home healthcare markets:

1. Rising Adoption of Advanced, Connected Infusion Technology

Manufacturers are increasingly embedding smart infusion pumps and dose-safety software into home infusion systems, improving delivery precision, reducing medication errors, and enabling better remote monitoring. These innovations are streamlining home-based care delivery and easing the workload on caregivers and home-care nurses. For instance, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump alongside Dose IQ Safety Software, extending integrated smart-pump capability into the home infusion setting and reinforcing patient safety.

2. Expanding Demand for Specialized, Condition-Specific Infusion Services

As more patients require complex, long-duration treatment for chronic conditions, demand for specialized home infusion nursing services tailored to individual disease states is rising sharply. These services deliver personalized therapy regimens directly in the home, reducing the need for repeat hospital visits while improving both comfort and long-term treatment adherence. For instance, in February 2024, Dynamic Access launched a dedicated home infusion nursing service for patients managing chronic autoimmune disorders and multiple sclerosis, partnering with more than 35 specialty pharmacies to deliver over 10,000 home visits annually across nine U.S. states.

3. Deepening Integration of Digital Health and Remote Monitoring Tools

The convergence of infusion devices with digital health platforms is enabling real-time data sharing between patients and care teams, allowing therapy progress to be tracked remotely and treatment plans adjusted without requiring in-person visits. For instance, in May 2024, Moog received U.S. FDA clearance for its CURLIN 8000 ambulatory infusion system, purpose-built for home infusion therapy and designed to integrate with the CURLIN RxManager platform for enhanced safety and oversight.

4. Growing Elderly Population and Preference for Home-Based Care

An expanding global elderly population, coupled with a broader consumer shift toward receiving treatment at home rather than in institutional settings, continues to be a foundational growth driver for the market. Home infusion allows elderly and chronically ill patients to remain in familiar surroundings while receiving clinically comparable care, a factor that is increasingly influencing both patient preference and provider treatment planning.

5. Supportive Reimbursement Frameworks and Cost-Efficiency Pressures

Healthcare payers and providers are placing growing emphasis on cost-effective treatment delivery, and home infusion therapy offers a materially lower cost base than equivalent inpatient care. Strong reimbursement systems in developed markets, particularly across North America, are supporting continued patient migration toward home-based infusion, even as the industry works to address challenges around consistent patient safety monitoring and caregiver training standardization.

Key Market Segmentation

By Product

Infusion Pumps – Largest Segment: Infusion pumps, spanning elastomeric, electromechanical, and gravity-based systems, represent the largest product segment, reflecting their central role in delivering precise, controlled medication dosing in the home setting. Their dominance is reinforced by continuous innovation in smart-pump platforms from manufacturers such as Baxter, whose Spectrum IQ pump has advanced remote monitoring capability for home-based care.

Intravenous Sets: IV administration sets remain an essential, recurring-consumption component of virtually every home infusion episode, supporting steady replacement demand across the installed base of home infusion patients.

IV Cannulas: Cannulas provide the vascular access point for home infusion delivery and represent a consistent volume driver tied directly to overall home infusion patient counts.

Needleless Connectors: Needleless connector systems support safer, lower-contamination-risk infusion line access, an increasingly important consideration as home infusion volumes scale outside clinical environments.

By Application

Anti-Infective – Largest Application: Anti-infective therapy leads application-based demand, driven by the increased use of home-administered intravenous antibiotics for severe infections such as pneumonia. Systems such as Smiths Medical’s CADD infusion platform support the precise delivery required for this segment’s continued adoption.

Endocrinology: Diabetes management and related hormone-therapy infusion needs constitute a significant and steadily growing application area within the market.

Hydration Therapy: Fluid-replacement infusion for athletes and general patients represents an emerging application supporting broader consumer adoption of home infusion services.

Chemotherapy, Enteral & Parenteral Nutrition, and Specialty Pharmaceuticals: These applications collectively support patients managing oncology treatment, long-term nutritional needs, and complex biologic drug regimens in a home setting, reflecting the market’s broadening scope beyond acute-care infusion use cases.

Regional Home Infusion Therapy Market Analysis

North America – Largest

United States & Canada; strong reimbursement systems, advanced home healthcare infrastructure, rising chronic disease prevalence, and a dense base of leading infusion therapy manufacturers

Europe: Germany, France, UK, Italy, Spain, Russia; expanding home-care networks and growing adoption of specialty infusion services

Asia-Pacific: China, Japan, India, South Korea, Australia, Indonesia; expanding healthcare infrastructure and rising demand for cost-effective, home-based chronic disease management

Latin America: Brazil, Mexico; growing private home-care adoption supporting increased home infusion test and treatment volumes

Middle East & Africa: Healthcare modernization initiatives supporting gradual expansion of home-based infusion therapy services

North America leads the global Home Infusion Therapy Market Share, underpinned by strong reimbursement systems, advanced home healthcare infrastructure, and a rapidly growing elderly population. Providers such as CVS Health have continued to expand home infusion service offerings, broadening patient access across the United States and reinforcing the region’s leadership position through supportive policy frameworks and continued technological investment.

Connect for Detailed Home Infusion Therapy Market Share Segmentation Analysis – Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=4098&flag=C

Leading Players in the Global Home Infusion Therapy Industry

The global home infusion therapy market features a mix of diversified medical device manufacturers and specialty home-care service providers. Key companies covered in the IMARC Group report include:

• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Eli Lilly and Company
• Fresenius SE & Co. KGaA
• ICU Medical Inc.
• JMS Co. Ltd.
• Nipro Corporation
• Option Care Health Inc. (Walgreen Co.)
• Smiths Group plc
• Terumo Corporation

About Us:

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Chemicals, Energy, Food & Beverages, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104